(eQTLs) in African ancestry populations are restricted to blood cells. This study aims to develop a map of genetically regulated transcripts expressed in tissues important for glucose homeostasis in AAs, critical for identifying the genetic etiology of T2D and related traits. Quantitative measures of adipose and muscle gene expression, and genotypic data were integrated in 260 non-diabetic AAs to identify expression regulatory variants. Their roles in genetic susceptibility to T2D, and related metabolic phenotypes, were evaluated by mining GWAS datasets. eQTL analysis identified 1971 and 2078 cis-eGenes in adipose and muscle, respectively. Cis-eQTLs for 885 transcripts including top ciseGenes CHURC1, USMG5, and ERAP2 were identified in both tissues. 62.1 % of top cis-eSNPs were within ±50 kb of transcription start sites and cis-eGenes were enriched for mitochondrial transcripts. Mining GWAS databases Abstract Relative to European Americans, type 2 diabetes (T2D) is more prevalent in African Americans (AAs). Genetic variation may modulate transcript abundance in insulin-responsive tissues and contribute to risk; yet, published studies identifying expression quantitative trait loci 
Introduction
The importance of genetic factors in modulating the susceptibility to type 2 diabetes (T2D) is well established (Groop and Pociot 2014) . Relative to European Americans, T2D is twice as prevalent in African Americans (Cowie et al. 2010 ) and associated risk factors such as insulin resistance and obesity are more prevalent (Cowie et al. 1993) . Whether genetic variation modulates molecular processes and contributes to the enhanced susceptibility to T2D in African Americans is unknown. Large-scale linkage, candidate-gene, and genome-wide association studies (GWAS), primarily in European and Asian populations, have identified approximately 88 loci associated with T2D and 83 loci associated with glucose homoeostasis-related phenotypes (Mohlke and Boehnke 2015) . T2D-associated loci identified in GWAS reveal relatively weak effects, together explaining only a small fraction of the heritability in African Americans (Mahajan et al. 2014; Ng et al. 2014) . Moreover, most associated variants are located in noncoding genomic regions. Thus, determining how these loci modulate systemic glucose homeostasis at the molecular level remains unclear. Approaches investigating molecular endophenotypes more proximal to gene products may assist in identifying the molecular basis of genetic susceptibility to T2D in African Americans.
Genetic variation can impact transcript abundance. We and others reported that T2D and related trait-associated variants are enriched for expression-regulatory single nucleotide polymorphisms (eSNPs) in tissues important for glucose homeostasis (Das and Sharma 2014; GTEx consortium 2015; Nicolae et al. 2010) . Identifying genetic variants associated with transcript expression in metabolically relevant tissues may identify functionally meaningful sets of SNPs involved in T2D, obesity, and related metabolic phenotypes. However, studies on the genetics of gene expression in populations of African ancestry are predominantly limited to lymphocytes/lymphoblastoid cell lines (Storey et al. 2007; Stranger et al. 2012; Zhang et al. 2008) . The goal of this study was to identify genetic regulatory variants modulating expression of adipose and muscle transcripts in African Americans at risk for T2D and evaluate their role in susceptibility to T2D, obesity, and related metabolic disorders. A systematic analysis was performed on the genome-wide transcript expression profiles of insulin-responsive tissues (subcutaneous adipose and skeletal muscle) and genome-wide SNP genotypes in a metabolically characterized cohort of 260 non-diabetic African Americans from North Carolina. To our knowledge, this is the largest existing cohort of non-diabetic African Americans characterized for gluco-metabolic phenotypes with available biological samples (DNA and tissue) for conducting an integrative multi-omics approach. These data were used to test two hypotheses: (1) expression levels of a subset of transcripts would associate with genotype and manifest as expression quantitative trait loci (eQTL) in both adipose and muscle, while a subset of transcripts would be modulated by tissue-specific eQTLs; and (2) a subset of the expression regulatory SNPs (eSNPs) would associate with glucose homeostasis-related phenotypes, obesity and/or T2D in large GWAS, identifying putative causal SNPs in African Americans.
Materials and methods

Human subjects
Participants were healthy, self-reported African Americans residing in North Carolina aged 18-60 years with a body mass index (BMI) between 18 and 42 kg/m 2 . A total of 260 unrelated non-diabetic individuals completed all study visits and are referred to as the "African American Genetics of Metabolism and Expression" (AAGMEx) cohort; subcutaneous adipose tissue (from the abdomen near the umbilicus) and skeletal muscle (from the vastus lateralis) biopsies were collected from 256 individuals. Studies were performed at the Wake Forest School of Medicine (WFSM) Clinical Research Unit. This study was approved by the WFSM Institutional Review Board and all participants provided written informed consent.
A standard 75-g oral glucose tolerance test (OGTT) was used to exclude individuals with diabetes and results were analyzed by homeostatic model assessment (HOMA; http://mmatsuda.diabetes-smc.jp/MIndex.html) to evaluate insulin sensitivity (Matsuda Index) and insulin resistance (HOMA-IR) (Matsuda and DeFronzo 1999; Matthews et al. 1985) . High-quality insulin modified (0.03 U/ kg) frequently sampled intravenous glucose tolerance test (FSIGT) data were available in 235 participants. The MIN-MOD Millennium program was used to analyze FSIGT data to determine insulin sensitivity (S I ) and acute insulin response (AIR G ) . Clinical, anthropometric, and physiological characteristics of the AAGMEx cohort have been described (Sharma et al. 2016) .
Gene expression analysis and genotyping
Genome-wide expression data were generated using HumanHT-12 v4 Expression BeadChip (Illumina, San Diego, CA, USA) whole genome gene expression arrays for quantitative analyses of transcript expression in adipose and muscle samples. Infinium HumanOmni5Exome-4 v1.1 DNA Analysis BeadChips (Illumina) were used to genotype DNA samples based on the manufacturer's recommendations. Additional technical details of standard gene expression analyses and genotyping methods are described in Supplementary methods.
Quality control
Detailed data quality control methods are presented in Supplementary methods. In brief, measures of glucose homeostasis and obesity were examined for outliers in a univariate fashion and as correlated pairs. Genome-wide gene expression data (probe level) for both the adipose and muscle samples were extracted separately using Illumina GenomeStudio V2011.1. Expression level was log 2 transformed, robust multi-array average normalized (RMA, includes quantile normalization) (Irizarry et al. 2003 ) and batch-corrected using ComBat (Johnson et al. 2007 ). The ) was used in eQTL analysis.
Statistical and bioinformatic analyses
To identify expression quantitative trait loci (eQTLs), linear regression was computed with the log 2 -transformed expression values as the outcome and an additive genetic model for the SNP as implemented in the R-package Matrix-EQTL (Shabalin 2012) ; age, gender, and African ancestry proportion were covariates. Analyses scanned for both cis and trans eQTLs, but partitioned the overall type 1 error rate of α = 0.05 into α = 0.04 for cis and α = 0.01 for trans. However, we considered as significant any cis-and trans-eSNPs with a false discovery rate (FDR)-corrected p value (Q value) <0.01 (or 1.0 %). Detailed statistical and bioinformatic data analysis methods are presented in Supplementary methods. Sample sizes in each analysis (Supplementary Table 1 ) varied based on available data after quality control.
Replication of eQTL data
Adipose cis-eQTL data from the Multiple Tissue Human Expression Resource (MuTHER) project (Grundberg et al. 2012) and muscle cis-eQTL data reported by Keildson et al. (Keildson et al. 2014) were mined to replicate ciseGenes identified in the AAGMEx cohort (Supplementary Methods). Additionally, replication of adipose and muscle cis-eGenes was tested in publically available tissue eQTL data from GTEx project (GTEx_Analysis_v6 updated) and lymphoblastoid cell line (LCL) eQTL data from both the Geuvadis RNA sequencing project and the SeeQTL data depository.
Integration of GWAS data
Cis-eSNPs identified in adipose and muscle of African Americans represented a prioritized set of SNPs providing statistical evidence for genotype-dependent variation in transcript abundance. The NHGRI catalog of published GWAS (Hindorff et al. 2009 ) and meta-analysis data from the Meta-Analyses of Glucose and Insulinrelated traits Consortium (MAGIC) (Scott et al. 2012) were mined to identify the role of putatively functional SNPs in T2D susceptibility and gluco-metabolic phenotypes. We also searched for associations of eSNPs with T2D and BMI in the Meta-analysis of Type 2 Diabetes in African Americans (MEDIA) Consortium and African Ancestry Anthropometry Genetic Consortium (AAAGC) (Monda et al. 2013 ) GWAS (Supplementary Methods).
Results eQTLs identified in adipose and muscle
We identified 1971 and 2078 transcripts with at least one significant cis-eQTL (top eSNP within ±500 kb around the expressed transcript at FDR <0.01) in adipose and muscle, respectively ( Fig. 1a, b ; Supplementary Tables 2 and 3) . These transcripts were considered cis-eGenes.
Overlap between cis-eGenes was identified in adipose and muscle. Cis-eQTLs for 885 transcripts were identified in both insulin-responsive tissues (Fig. 1b) . Among these, 317 were most strongly associated with the same ciseSNPs in both tissues and showed the same direction of effect ( Fig. 1c ; Supplementary Table 4 ). The most significant cis-eGenes (FDR <1 × 10 −100 ) observed in both tissues included churchill domain containing 1 (CHURC1), up-regulated during skeletal muscle growth-homolog 5 (USMG5), and endoplasmic reticulum aminopeptidase 2 (ERAP2) ( Table 1). SNP-transcript expression level associations for variants located on other chromosomes or outside the defined cis boundary (±500 kb around the transcript) were examined to identify trans-regulatory variants. Associations were identified (FDR < 0.01) for expression of 603 and 943 transcripts with a genotype of at least one trans-eSNP in adipose and muscle, respectively (data not shown). Considering the large number of tests performed to identify transeQTLs, we conservatively considered a transcript associated with >1 trans-eSNP as statistically significant. Using this conservative criterion, 322 and 591 trans-eGenes were identified in adipose and muscle, respectively. Overlap of these trans-eGenes with cis-eGenes is shown in Fig. 1b . Summary statistics of all cis-and trans-eSNPs is publically accessible through a searchable database at https://mdsetaa. phs.wakehealth.edu.
Genomic distribution of cis-eSNPs
The distribution of the top cis-eSNPs for each transcript was assessed in relation to gene proximity and plotted against the distribution of distances between cis-eSNPs with the lowest p values and transcription start site (TSS). As reported (Stranger et al. 2005 (Stranger et al. , 2007 Veyrieras et al. 2008) , the majority of top cis-eSNPs in adipose (62.6 %) and muscle (61.7 %) were located within ±50 kb of the TSS (Fig. 2a, b) . For adipose, 80 and 95 % of the top ciseSNPs were within 118.6 and 374.4 kb, respectively, of the TSS. For muscle, these distances were 122.8 and 371.4 kb, respectively. Cis-eSNPs with larger effect sizes were also overrepresented close to TSS (Fig. 2c, d ). Greater than 80 % (80.8 % in adipose; 84 % in muscle) of the highly significant cis-eSNPs (p value <1 × 10 −10 ) were located within ±100 kb of the TSS. To assess potential functional significance, we annotated the genomic locations (based on the Sequence Ontology definitions) of the top cis-eSNPs of associated transcripts (FDR <0.01). Interestingly, 79.6 % of the top cis-eSNPs were located within or near gene regions (±5 kb), and only 20.4 % were intergenic. Most of the top cis-eSNPs were intronic (43.1 %) or in the 3′ or 5′ untranslated regions (UTR, 16.3 %, Fig. 3 ). Utilizing the TRANS-FAC Database, SNPnexus (Dayem Ullah et al. 2012) annotation predicted the disruption of transcription factor binding sites by 80 and 77 top cis-eSNPs in adipose and muscle, respectively.
In silico analyses indicate functional significance of cis-eGenes
Gene-annotation enrichment analysis with DAVID (Huang et al. 2009) , 288 genes) cis-eGenes identified. Expression of a subset of cis-eGenes (362 in adipose; 42 in muscle) was associated with S I in this non-diabetic African American cohort (Sharma et al. 2016 ).
Replication of cis-eQTLs using publically available data
Published studies for eQTLs in insulin-responsive tissues in African Americans are not available. Replication of eQTLs was assessed by mining published adipose and Table 5 ), supporting replication of 73.5 % of top adipose cis-eQTLs in our AAGMEx cohort.
Muscle cis-eQTLs as reported by Keildson et al. (2014) were searched to assess replication of these cis-eGenes (n = 287) in the AAGMEx cohort, considering all probes representing significant (up to FDR <0.04) cis-eGenes.
Comparison of the two muscle-eQTL datasets showed an association of 144 cis-eGenes (represented by 191 probes, Supplementary Table 6 ). Despite the small sample and different design of the previous study by Keildson et al., 50 .2 % of their muscle-eGenes were replicated in our AAGMEx African American cohort. Despite different methods of transcript quantification (RNA-seq) and sample characteristics (N = 298 and 361 cadaver donors for subcutaneous adipose and skeletal muscle, respectively), results from GTEx (GTEx_Analysis_v6 updated: 2015-06-18, dbGaP Accession phs000424.v6.p1) (GTEx consortium 2015) supported replication of 965 adipose cis-eGenes and 1016 muscle cis-eGenes from AAGMEx (data not shown).
To determine the replication of adipose and muscle tissue cis-eGenes in surrogate tissues, publically available eQTL data for transformed lymphoblastoid cell lines (LCL) were searched. The LCL-eQTL data from a small African ancestry cohort (Geuvadis RNA sequencing project of 1000 Genomes YRI samples, N = 89; http://www.geuvadis.org/web/geuvadis/RNAseq-project) replicated 96 and 95 adipose and muscle tissue-identified cis-eGenes, respectively. However, replication was much higher when larger LCL-eQTL datasets, e.g. HapMap3 consensus cis-eQTL (SeeQTL; http://www.bios.unc.edu/research/genomic_soft-ware/seeQTL) were searched for comparison. Considering cis-eGenes at q < 0.01 from SeeQTL data, ~24 % of AAGMEx adipose and muscle cis-eGenes (448 in adipose; 443 in muscle) were replicated in LCLs. Thus, expression of a subset of transcripts is genetically regulated across tissues, and the eQTL data from LCLs may be used as a proxy for identifying a small subset of adipose and muscle tissue cis-eGenes.
Association of cis-eSNPs with T2D, obesity and related metabolic phenotypes
The NHGRI catalog of published GWAS (from UCSC table browser) was mined (Hindorff et al. 2009 ) for association of all significant cis-eSNPs (FDR <0.01) for adipose and muscle transcripts to identify potential roles in T2D susceptibility and related phenotypes. This catalog only includes phenotype-associated index SNPs (p < 1.0 × 10 −5 ), mostly from people not of recent African descent. Association of cis-eSNPs was detected for >50 genes with gluco-metabolic phenotypes including T2D (e.g. PIK3C2A, RBMS1, UFSP1, ACHE), fasting plasma glucose (e.g. NOSTRIN, RREB1), hemoglobin A1c (e.g. FN3KRP), and BMI and obesity-related traits (e.g. POMC, MARCH6, NINJ1, RBP1, HMBOX1, CHURC1, CPEB4; Supplementary Table 7) .
GWAS data from Caucasians in the MAGIC cohort (Scott et al. 2012) were assessed for glucose homeostasis phenotypes; Supplementary Table 8 lists cis-eSNPs for 54 adipose and 63 muscle genes with evidence for association (p < 0.01) with glucose homeostasis phenotypes. An eSNP (both adipose and muscle) for inositol polyphosphate-5-phosphatase (INPP5E) was strongly associated with fasting glucose (rs1128905, p = 5.81 × 10 −9 ), and an eSNP for ERAP2 was strongly associated with 2 h-glucose (rs1019503, p = 8.97 × 10 −9 ). Interestingly, rs560887, located in the intron of the glucose-6-phosphatase catalytic subunit 2 gene (G6PC2), was strongly associated with fasting glucose (p = 1.4 × 10 −178 ) in Caucasians in the MAGIC cohort, as was a cis-eSNP for NOSTRIN (nitric oxide synthase trafficker gene) in adipose of people in the AAGMEx cohort. Muscle eSNPs rs2068834 (sorting nexin 17 gene, SNX17; p = 9.78 × 10 −20 ) and rs11715915 (macrophage-stimulating 1 gene, MST1; p = 4.90 × 10 −8 ) associated with fasting glucose; eSNP rs6912327 (UHRF1-binding protein 1 gene, UHRF1BP1) associated with BMI-adjusted fasting insulin (p = 2.26 × 10 −8 ). A search for association of eSNPs (FDR <0.01) with T2D and BMI was performed in GWAS from MEDIA and AAAGC (Monda et al. 2013) . CiseSNPs for 72 genes in adipose and 80 genes in muscle showed nominal evidence (p < 0.01) of association with T2D in African Americans in the MEDIA cohort (Supplementary Table 9 ). Three cis-eSNPs show stronger association (p < 1.0 × 10 −4 ) with T2D (Table 2a) . A cis-eSNP for the transcript of ATP synthase subunits-like protein (ATP5SL) gene was most significantly associated with T2D (rs7259208, p = 1.20 × 10
−5
). Cis-eSNPs for 65 genes in adipose and 91 genes in muscle showed nominal evidence of association (p < 0.01) with BMI in African Americans in the AAAGC cohort (Supplementary Table 10 ). Four cis-eSNPs show stronger association (p < 1.0 × 10 −4 ) with BMI (Table 2b) . Among the selected subset of ciseSNPs, rs4074110 (methylcrotonoyl-CoA carboxylase 1, MCCC1) showed the most significant association with BMI (p = 6.11 × 10 −6 ) in meta-analyses from AAAGC data. Thus, cis-eSNPs may modulate the risk for T2D and obesity in African Americans. 
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Integration of AAGMEx eQTL results and GWAS of gluco-metabolic traits suggested putative target genes for GWAS-identified SNPs. A total of 216 and 249 target ciseGenes in adipose and muscle, respectively, were identified. Among these target cis-eGenes, mRNA expression of 55 genes in adipose and 20 genes in muscle was significantly associated (p < 0.001) with the glucose homeostasis traits (S I and AIR G derived from FSIGT; HOMA-IR and Matsuda index derived from OGTT), or obesity (BMI) phenotypes of AAGMEx participants (Supplementary  Table 11 ).
Discussion
Despite successes in GWAS, the majority of loci accounting for T2D heritability remain unknown and the diversity of its pathophysiology, molecular mechanisms, and variants explaining enhanced susceptibility in African Americans are poorly understood. The present study combined gene expression in tissues important to insulin action, and genome-wide genotype data in African Americans to fill these gaps. Results provide a comprehensive map of genetically regulated transcripts in African Americans, which is critical for prioritizing GWAS-identified SNPs in replication studies and detecting functional roles of variants involved in T2D and related traits.
Integration of genome-wide expression and genotype data enabled mapping of loci involved in the regulation of gene expression. Association of SNPs with transcript levels of nearby (cis) or distal (trans) genes was identified. Compared to adipose, slightly more cis-eQTL transcripts (cis-eGenes) were found in muscle. Overlap of 885 ciseQTL transcripts (~45 % of cis-eGenes) was seen in both tissues indicating tissue-independent expression regulatory elements. Significant cis-eGenes observed in both tissues included USMG5 and ERAP2. The USMG5 gene, also known as the diabetes-associated protein in insulin-sensitive tissue gene (DAPIT), is differentially modulated in insulin-responsive tissues of streptozotocin-treated diabetic rats (Kontro et al. 2012; Paivarinne and Kainulainen 2001) . ERAP2 is involved in maturation of many proteins in the endoplasmic reticulum (ER), and has been implicated in regulation of angiogenesis and blood pressure (Cifaldi et al. 2012 ). An eSNP for ERAP2 was strongly associated with 2 h-glucose in the MAGIC cohort. Consistent with published eQTL studies (Stranger et al. 2005 , Veyrieras et al. 2008 , top cis-eSNPs for 60 % of transcripts in both tissues were within ± 50 kb of the TSS. The genomic distribution of cis-eSNPs fits with existing knowledge on the genetic regulatory architecture of transcript expression. Further bioinformatic annotation of these loci indicated the disruption of transcription factor binding by eSNPs and provided evidence for regulatory motifs. Thus, the identified eQTLs support the concept that functional regulatory genomic regions exist in glucose homeostasis-regulating tissues. Many cis-eQTLs identified in this African American cohort were replicated in non-African cohorts. Thus, a subset of genetic regulatory mechanisms of transcript expression is common between African Americans and non-Africans. Further studies will be required to confirm, whether other subsets of genetic regulatory mechanisms of transcript expression predominately influence particular ancestral groups.
Enrichment (DAVID analysis) of mitochondrial genes was identified among adipose and muscle cis-eGenes, indicating a role for genetic factors in modulation of this pathway. IPA revealed enrichment of pathways involved in mitigating oxidative stress (including glutathione-mediated detoxification, p = 8.32 × 10 −3 -3.72 × 10 −5 ; NRF2-mediated oxidative stress response, p = 0.02-4.47 × 10 −4 ) among cis-eGenes. These biological pathways may play key roles in modulating insulin sensitivity in African Americans.
Compared to cis-eQTLs, the effect sizes of trans-eQTLs are generally small, requiring larger sample sizes for robust detection of trans-eQTLs (Grundberg et al. 2012) . A recent eQTL analysis in adipose tissue from Caucasian female twins (MuTHER Project, N = 856) identified 3529 ciseQTLs (at FDR 1 %) and 639 trans-eQTLs (at FDR 10 %) (Grundberg et al. 2012) . A stringent threshold (FDR < 1 %, with corresponding uncorrected p values <2.6 × 10 −9 in adipose tissue) was used to account for the large number of tests performed for trans-eQTL analysis in the AAGMEx cohort, and it identified 322 and 591 trans-eGenes in adipose and muscle, respectively. Thus, the number of transeGenes identified in AAGMEx is consistent with expectations and comparable to published studies on adipose and other tissues.
Mining of the NHGRI catalog of GWAS (Hindorff et al. 2009 ) and MAGIC GWAS meta-analysis (Scott et al. 2012) results revealed association of cis-eSNPs in this study with T2D and related phenotypes. Although these SNP-disease association results are primarily from cohorts of individuals not of African descent, integration of eQTL data from our African American participants suggests molecular mechanisms that are putatively regulated by these SNPs and sequentially modulating disease susceptibility.
Cis-eSNPs for many adipose and muscle transcripts showed association with T2D and BMI in MEDIA and AAAGC (Monda et al. 2013 ) African Americans, supporting roles for these transcripts in T2D. Genes modulated by disease-associated cis-eSNPs (e.g., CD36, CAMK2A, IRS2, POMC, TLR4, XBP1) are involved in the pathophysiology of T2D, obesity and related traits; whereas the roles of other cis-eGenes (e.g. ADAL, ATP5SL, MCCC1) 1 3 are unknown. Interestingly, among the target cis-eGenes for these GWAS-identified SNPs, mRNA expression of 55 genes in adipose and 20 genes in muscle was significantly associated with glucose homeostasis or obesity phenotypes in AAGMEx African Americans. This observation suggests a putative role for these GWAS-identified SNPs and respective cis-eGenes in the pathophysiology of T2D and related metabolic diseases. Association summary statistics were available from the MEDIA and AAAGC cohorts for directly genotyped SNPs and HapMap reference panel imputed SNPs. Association results for a subset of cis-eSNPs or their proxies (those that were not among the HapMap SNPs) were not available from these GWAS. Thus, the role of ciseSNPs of several transcripts identified in this study cannot be evaluated in the MEDIA and AAAGC cohorts.
Target cis-eGenes of T2D-associated SNPs from MEDIA African Americans overlapped with target ciseGenes of glucose homeostasis trait-associated SNPs from MAGIC Caucasians. Cis-eSNPs for 18 genes (ACAD10, CUL3, G3BP2, GIN1, HLA-DPA1, HSPA1B, KCTD10, NOTCH4, PFDN1, PPM1 M, RNF41, SNX17, ST7L, STARD10, TIPARP, TMEM116, and WDR6) were associated with T2D in MEDIA African Americans and were also associated with glucose homeostasis phenotypes (e.g., fasting glucose, 2 h-OGTT glucose and fasting insulin) in Caucasians from MAGIC. Similarly, target cis-eGenes of BMI-associated SNPs from AAAGC African Americans overlapped with target cis-eGenes of glucose homeostasis trait-associated SNPs from MAGIC Caucasians. CiseSNPs for 12 genes (APIP, ASAP3, BCS1L, GIN1, HSPA1B, PPP1CB, RABEP1, RPP40, SNX17, TMEM60, TOM1, and UHRF1BP1) were associated with BMI in AAAGC African Americans and were also associated with glucose homeostasis phenotypes in MAGIC Caucasians. Thus, regulatory SNP-mediated modulation of the transcript expression of some target genes may modulate susceptibility to T2D and related gluco-metabolic phenotypes in individuals with either African or European ancestry.
In conclusion, this study identified genetic loci influencing the expression of several genes in adipose and muscle of African Americans. Additionally, this study provides data on molecular mechanisms putatively regulated by eSNPs and sequentially modulating susceptibility for T2D and related metabolic phenotypes in African Americans.
